Carbon Health announced today that it is launching a new clinical research initiative. The new program will be made available to patients looking to gain access to breakthrough treatments and companies looking to collaborate on clinical trials.
Related Reading:
- Apple bolstering its Health Technology team with Clinical Studies specialists and Legal Counsel for Health
- Facebook’s Health Technology Group and Reality Labs hiring Clinical Research personnel
- Google’s new AI-Powered health tool helps you understand skin conditions using your phone’s camera
The program’s Clinical Research Administrator, Niree Hindoyan, will guide the development and execution of research studies. As a former research specialist at Cedars-Sinai and a Research Program Coordinator at Weill Cornell Medicine, Niree has coordinated nearly 100 research studies.
In the press release, Niree said that “Clinical research gives us hope for a better tomorrow. Carbon Health gives us hope for better care. Together, the potential is unbounded. I am looking forward to assisting with the growth of this novel program!”.
Through Carbon Health’s Clinical Research Division and the company’s clinics nationwide, it aims at building the best clinical site platform for a sponsor to work with to bring drugs, diagnostics, and other technologies to market much faster.
The new initiative will allow Carbon Health to provide partners with a large, diverse patient pool and geographic reach for their studies.
Carbon Health has recently been in the news due to several reasons. This month, it made headlines by hiring away the head of Apple’s health strategic initiatives, Myoung Cha.
The company had hired technology leader Claire Hough in February as the new Chief Technology Officer (CTO). Hough now leads the platform and product engineering teams at Carbon Health in its continued pursuit to develop technology that improves access to healthcare.
The technology-enabled healthcare provider secured $100 million in Series C funding led by Dragoneer Investment Group, with participation from existing investors Brookfield Technology Partners (BTP), DCVC, and Builders VC in November 2020.